Symposium Faculty and Planning Committee | |
FACULTY Ashraf Aziz, MD
Gary L. Buchschacher, Jr., MD, PhD Elizabeth Budde, MD, PhD Assistant Professor Department of Hematology & Hematopoietic Cell Transplantation City of Hope Los Angeles, CA
Maria Caceres, MSN, BSN, RN, PHN Regional Director, Radiation Oncology Department Southern California Permanente Medical Group Los Angeles, San Bernardino and Orange County, CA Patrick Courneya, MD Executive Vice President and Chief Medical Officer Kaiser Foundation Health Plan, Inc. and Hospitals Oakland, CA Lara Durna, MD Hematology/Oncology Southern California Permanente Medical Group Los Angeles, CA Nancy Gin, MD Exec VP, Quality and Chief Quality Officer The Permanente Federation Regional Medical Director of Quality & Clinical Analysis Southern California Permanente Medical Group Pasadena, CA
Andrea Harzstark, MD Urologic Oncology The Permanente Medical Group Oakland, CA Monika Krzyzanowska, MD, MPH, FRCPC Director, Quality Program Division of Medical Oncology & Hematology Professor, Department of Medicine Senior Adjunct Scientist Princess Margaret Cancer Centre Institute of Clinical Evaluative Sciences University of Toronto Toronto, Canada
Scott Lentz, MD Chunnan Liu, MD Ruan Ramjit, MD Oncology Southern California Permanente Medical Group Los Angeles, CA Jennifer Marie Suga, MD Oncology The Permanente Medical Group Valejo, CA Hyma Vempaty, MD Oncology The Permanente Medical Group Santa Clara, CA FACULTY DISCLOSURE STATEMENT Kaiser Permanente requires that all planners and faculty participating in CME activities disclose any financial relationship with a commercial interest that might pose a potential, apparent, or real conflict of interest with regard to the individual's contribution to the activity. A commercial interest is defined by the Accreditation Council for Continuing Medical Education (ACCME) as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients; the most common examples are pharmaceutical and medical device companies. All potential conflicts of interest are mitigated prior to the start of the conference and in accordance with the policies of the KP National CME Program. |
COMMITTEE Co-Chairs: Robert M. Cooper, MD* Physician Director – Cancer Program Southern California Permanente Medical Group Los Angeles, CA Yan Li, MD, PhD* Chief of Hematology/Oncology Department Oakland Medical Center Northern California Permanente Medical Group Oakland, CA Committee: Farah Brasfield, MD* Regional Chief, Hematology/Oncology Southern California Permanente Medical Group Anaheim, CA Reina Haque, PhD, MPH* Research Scientist III – Department of Research & Evaluation Southern California Permanente Medical Group Pasadena, CA Tatjana Kolevska, MD* Regional Chief, Hematology/Oncology The Permanente Medical Group Vallejo, CA Lawrence H. Kushi, ScD* Director of Scientific Policy – Division of Research Kaiser Permanente Division of Research Oakland, CA
Alexander Menter, MD*
Oncology Colorado Permanente Medical Group Denver, CO Helen H. Moon, MD* The Permanente Federation National CME Office Sarah Shimer, MPH SCPMG Physician Education Carol O’Neal Katherine M. Kleine Amy Tam Sr. Meeting Planner Southern California Permanente Medical Group Pasadena, CA
|